While inconsistent dosing could have played a role, it still may be possible to identify the patients most likely to see ...

Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron ...

Ferric carboxymaltose, an IV iron replacement therapy, did not reduce the time to first HF hospitalization or CV death for patients with HF and iron deficiency, according to results of a late-breaking ...

A new study lacked significant results, but when combined with additional studies, the prevention of cardiovascular events ...

At present, there appears to be enough scientific support for the use of intravenous iron supplementation to improve hemoglobin responses in anemic patients with cancer, and this has been included ...